{"id":"diclofenac-etalhyaluronate-sodium","rwe":[{"pmid":"37808967","year":"2023","title":"Anaphylactic shock due to intra-articular injection of diclofenac etalhyaluronate sodium: A case report.","finding":"","journal":"Acute medicine & surgery","studyType":"Clinical Study"},{"pmid":"35223043","year":"2022","title":"Repeated anaphylactic reaction after walking following an intraarticular injection of diclofenac etalhyaluronate sodium during a 3-day period.","finding":"","journal":"Acute medicine & surgery","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Prostaglandin E2 receptor EP2 subtype","category":"target"},{"label":"PTGER2","category":"gene"},{"label":"Active","category":"status"},{"label":"Osteoarthritis of hip","category":"indication"},{"label":"Osteoarthritis of knee","category":"indication"},{"label":"Seikagaku Corporation","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Seikagaku Corporation","patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$1.9196/ML","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$691","description":"DICLOFENAC 0.1% EYE DROPS","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=diclofenac etalhyaluronate sodium","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:39:00.471241+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:39:05.720613+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=diclofenac etalhyaluronate sodium","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:39:06.093239+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cyclooxygenase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:39:08.191016+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297232/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:39:07.851789+00:00"}},"allNames":"joycle","offLabel":[],"synonyms":["diclofenac etalhyaluronate sodium","joycle","SI-613","ONO 5704","ONO-5704/SI-613"],"timeline":[{"date":"2021-03-23","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Seikagaku Corporation)"}],"approvals":[{"date":"2021-03-23","orphan":false,"company":"Seikagaku Corporation","regulator":"PMDA"}],"brandName":"Joycle","ecosystem":[{"indication":"Osteoarthritis of hip","otherDrugs":[],"globalPrevalence":655000000},{"indication":"Osteoarthritis of knee","otherDrugs":[],"globalPrevalence":655000000}],"mechanism":{"target":"Prostaglandin E2 receptor EP2 subtype","targets":[{"gene":"PTGER2","source":"DrugCentral","target":"Prostaglandin E2 receptor EP2 subtype","protein":"Prostaglandin E2 receptor EP2 subtype"}],"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Joycle (diclofenac etalhyaluronate sodium) is a selective antagonist of the prostaglandin E2 receptor EP2 subtype, which plays a key role in mediating pain and inflammation in osteoarthritis."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5489","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=diclofenac etalhyaluronate sodium","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:34:28.802345","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:39:09.427207+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"alprostadil","drugSlug":"alprostadil","fdaApproval":"1981-10-16","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"cloprostenol","drugSlug":"cloprostenol","fdaApproval":"","relationship":"same-target"},{"drugName":"dinoprost","drugSlug":"dinoprost","fdaApproval":"1976-05-18","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"dinoprostone","drugSlug":"dinoprostone","fdaApproval":"1977-08-23","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"iloprost","drugSlug":"iloprost","fdaApproval":"2004-12-29","patentExpiry":"Jul 18, 2044","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"indomethacin","drugSlug":"indomethacin","fdaApproval":"1965-06-10","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"mezlocillin","drugSlug":"mezlocillin","fdaApproval":"1981-09-21","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"misoprostol","drugSlug":"misoprostol","fdaApproval":"1988-12-27","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"omidenepag isopropyl","drugSlug":"omidenepag-isopropyl","fdaApproval":"2022-09-22","patentExpiry":"Oct 13, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"rofecoxib","drugSlug":"rofecoxib","fdaApproval":"1999-05-20","patentStatus":"Unknown","relationship":"same-target"}],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"genericName":"diclofenac etalhyaluronate sodium","indications":{"approved":[{"name":"Osteoarthritis of hip","source":"DrugCentral","snomedId":239872002,"regulator":"FDA","usPrevalence":null,"globalPrevalence":655000000,"prevalenceMethod":"curated","prevalenceSource":"Arthritis Res Ther, 2023 (PMID:36991481)"},{"name":"Osteoarthritis of knee","source":"DrugCentral","snomedId":239873007,"regulator":"FDA","usPrevalence":null,"globalPrevalence":655000000,"prevalenceMethod":"curated","prevalenceSource":"Arthritis Res Ther, 2023 (PMID:36991481)"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"alprostadil","brandName":"alprostadil","genericName":"alprostadil","approvalYear":"1981","relationship":"same-target"},{"drugId":"cloprostenol","brandName":"cloprostenol","genericName":"cloprostenol","approvalYear":"","relationship":"same-target"},{"drugId":"dinoprost","brandName":"dinoprost","genericName":"dinoprost","approvalYear":"1976","relationship":"same-target"},{"drugId":"dinoprostone","brandName":"dinoprostone","genericName":"dinoprostone","approvalYear":"1977","relationship":"same-target"},{"drugId":"iloprost","brandName":"iloprost","genericName":"iloprost","approvalYear":"2004","relationship":"same-target"},{"drugId":"indomethacin","brandName":"indomethacin","genericName":"indomethacin","approvalYear":"1965","relationship":"same-target"},{"drugId":"mezlocillin","brandName":"mezlocillin","genericName":"mezlocillin","approvalYear":"1981","relationship":"same-target"},{"drugId":"misoprostol","brandName":"misoprostol","genericName":"misoprostol","approvalYear":"1988","relationship":"same-target"},{"drugId":"omidenepag-isopropyl","brandName":"omidenepag isopropyl","genericName":"omidenepag isopropyl","approvalYear":"2022","relationship":"same-target"},{"drugId":"rofecoxib","brandName":"rofecoxib","genericName":"rofecoxib","approvalYear":"1999","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"LG1II3835L","UMLSCUI":"C5420904","chemblId":"CHEMBL4297232","ChEMBL_ID":"CHEMBL4297232","KEGG_DRUG":"D11020","MESH_SUPPLEMENTAL_RECORD_UI":"C000656259"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Seikagaku Corporation","relationship":"Current Owner"}],"publicationCount":2,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"recentPublications":[{"date":"2023 Jan-Dec","pmid":"37808967","title":"Anaphylactic shock due to intra-articular injection of diclofenac etalhyaluronate sodium: A case report.","journal":"Acute medicine & surgery"},{"date":"2022 Jan-Dec","pmid":"35223043","title":"Repeated anaphylactic reaction after walking following an intraarticular injection of diclofenac etalhyaluronate sodium during a 3-day period.","journal":"Acute medicine & surgery"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Seikagaku Corporation","companyId":"seikagaku-corporation","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2021-03-23T00:00:00.000Z","mah":"Seikagaku Corporation","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:39:09.427207+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}